Sign In

Login

Password

Forgot Password ? Sign Up

Palbociclib (Vietnamese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Palbociclib" in Vietnamese language version.

refsWebsite
Global rank Vietnamese rank
7nih.gov
4th place
7th place
5doi.org
2nd place
2nd place
5web.archive.org
1st place
1st place
3pfizer.com
low place
low place
3fda.gov
447th place
625th place
2worldcat.org
5th place
13th place
2nytimes.com
7th place
23rd place
2cancer.gov
1,684th place
1,442nd place
2nice.org.uk
3,258th place
6,247th place
1onclive.com
low place
low place
1seekingalpha.com
5,344th place
3,904th place
1europa.eu
68th place
114th place
1bbc.com
20th place
29th place
1yahoo.com
38th place
77th place
1aacr.org
low place
low place
1dailymail.co.uk
219th place
216th place
1reuters.com
49th place
78th place
1g1therapeutics.com
low place
low place

aacr.org

bbc.com

cancer.gov

dailymail.co.uk

doi.org

  • Finn, RS; Dering, J; Conklin, D; Kalous, O; Cohen, DJ; Desai, AJ; Ginther, C; Atefi, M; và đồng nghiệp (2009). “PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro”. Breast Cancer Research: BCR. 11 (5): R77. doi:10.1186/bcr2419. PMC 2790859. PMID 19874578.
  • Rocca A, Farolfi A, Bravaccini S, Schirone A, Amadori D (2014). “Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer”. Expert Opin Pharmacother. 15 (3): 407–20. doi:10.1517/14656566.2014.870555. PMID 24369047.
  • Xu, Hanxiao; Yu, Shengnan; Liu, Qian; Yuan, Xun; Mani, Sridhar; Pestell, Richard G.; Wu, Kongming (ngày 24 tháng 4 năm 2017). “Recent advances of highly selective CDK4/6 inhibitors in breast cancer”. Journal of Hematology & Oncology. 10 (1): 97. doi:10.1186/s13045-017-0467-2. ISSN 1756-8722. PMC 5404666. PMID 28438180.
  • Finn; và đồng nghiệp (ngày 17 tháng 11 năm 2016). “Palbociclib and Letrozole in Advanced Breast Cancer”. New England Journal of Medicine. 375 (20): 1925–1936. doi:10.1056/NEJMoa1607303. PMID 27959613.
  • Turner, Nicholas C.; Ro, Jungsil; André, Fabrice; Loi, Sherene; Verma, Sunil; Iwata, Hiroji; Harbeck, Nadia; Loibl, Sibylle; Huang Bartlett, Cynthia (ngày 16 tháng 7 năm 2015). “Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer”. New England Journal of Medicine. 373 (3): 209–219. doi:10.1056/NEJMoa1505270. ISSN 0028-4793. PMID 26030518.

europa.eu

ema.europa.eu

fda.gov

fda.gov

accessdata.fda.gov

g1therapeutics.com

nice.org.uk

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Finn, RS; Dering, J; Conklin, D; Kalous, O; Cohen, DJ; Desai, AJ; Ginther, C; Atefi, M; và đồng nghiệp (2009). “PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro”. Breast Cancer Research: BCR. 11 (5): R77. doi:10.1186/bcr2419. PMC 2790859. PMID 19874578.
  • Rocca A, Farolfi A, Bravaccini S, Schirone A, Amadori D (2014). “Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer”. Expert Opin Pharmacother. 15 (3): 407–20. doi:10.1517/14656566.2014.870555. PMID 24369047.
  • Xu, Hanxiao; Yu, Shengnan; Liu, Qian; Yuan, Xun; Mani, Sridhar; Pestell, Richard G.; Wu, Kongming (ngày 24 tháng 4 năm 2017). “Recent advances of highly selective CDK4/6 inhibitors in breast cancer”. Journal of Hematology & Oncology. 10 (1): 97. doi:10.1186/s13045-017-0467-2. ISSN 1756-8722. PMC 5404666. PMID 28438180.
  • Finn; và đồng nghiệp (ngày 17 tháng 11 năm 2016). “Palbociclib and Letrozole in Advanced Breast Cancer”. New England Journal of Medicine. 375 (20): 1925–1936. doi:10.1056/NEJMoa1607303. PMID 27959613.
  • Turner, Nicholas C.; Ro, Jungsil; André, Fabrice; Loi, Sherene; Verma, Sunil; Iwata, Hiroji; Harbeck, Nadia; Loibl, Sibylle; Huang Bartlett, Cynthia (ngày 16 tháng 7 năm 2015). “Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer”. New England Journal of Medicine. 373 (3): 209–219. doi:10.1056/NEJMoa1505270. ISSN 0028-4793. PMID 26030518.

ncbi.nlm.nih.gov

  • Finn, RS; Dering, J; Conklin, D; Kalous, O; Cohen, DJ; Desai, AJ; Ginther, C; Atefi, M; và đồng nghiệp (2009). “PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro”. Breast Cancer Research: BCR. 11 (5): R77. doi:10.1186/bcr2419. PMC 2790859. PMID 19874578.
  • Xu, Hanxiao; Yu, Shengnan; Liu, Qian; Yuan, Xun; Mani, Sridhar; Pestell, Richard G.; Wu, Kongming (ngày 24 tháng 4 năm 2017). “Recent advances of highly selective CDK4/6 inhibitors in breast cancer”. Journal of Hematology & Oncology. 10 (1): 97. doi:10.1186/s13045-017-0467-2. ISSN 1756-8722. PMC 5404666. PMID 28438180.

nytimes.com

onclive.com

pfizer.com

reuters.com

seekingalpha.com

web.archive.org

worldcat.org

yahoo.com

news.yahoo.com